Vanda Pharmaceuticals (VNDA) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $3.5 million.
- Vanda Pharmaceuticals' Treasury Shares rose 2777.82% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 2777.82%. This contributed to the annual value of $2.7 million for FY2024, which is 3908.53% up from last year.
- Vanda Pharmaceuticals' Treasury Shares amounted to $3.5 million in Q3 2025, which was up 2777.82% from $3.5 million recorded in Q2 2025.
- Vanda Pharmaceuticals' 5-year Treasury Shares high stood at $3.5 million for Q2 2025, and its period low was $1.8 million during Q4 2021.
- For the 5-year period, Vanda Pharmaceuticals' Treasury Shares averaged around $2.3 million, with its median value being $2.0 million (2023).
- As far as peak fluctuations go, Vanda Pharmaceuticals' Treasury Shares tumbled by 233.36% in 2023, and later surged by 4205.35% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' Treasury Shares (Quarter) stood at $1.8 million in 2021, then grew by 8.55% to $1.9 million in 2022, then dropped by 0.53% to $1.9 million in 2023, then surged by 39.09% to $2.7 million in 2024, then surged by 31.33% to $3.5 million in 2025.
- Its Treasury Shares was $3.5 million in Q3 2025, compared to $3.5 million in Q2 2025 and $3.3 million in Q1 2025.